Hereditary ovarian cancer: biology, response to chemotherapy and prognosis.
about
Small molecule inhibitor of the RPA70 N-terminal protein interaction domain discovered using in silico and in vitro methods.'BRCAness' and its implications for platinum action in gynecologic cancer.Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients.
P2860
Hereditary ovarian cancer: biology, response to chemotherapy and prognosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hereditary ovarian cancer: biology, response to chemotherapy and prognosis.
@en
Hereditary ovarian cancer: biology, response to chemotherapy and prognosis.
@nl
type
label
Hereditary ovarian cancer: biology, response to chemotherapy and prognosis.
@en
Hereditary ovarian cancer: biology, response to chemotherapy and prognosis.
@nl
prefLabel
Hereditary ovarian cancer: biology, response to chemotherapy and prognosis.
@en
Hereditary ovarian cancer: biology, response to chemotherapy and prognosis.
@nl
P2860
P356
P1433
P1476
Hereditary ovarian cancer: biology, response to chemotherapy and prognosis.
@en
P2093
Tamar Safra
P2860
P304
P356
10.2217/WHE.09.40
P577
2009-09-01T00:00:00Z